1. Market Research
  2. > All Companies
  3. > MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis Review


MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeutic, diagnostic and research applications. It offers therapeutic drugs for various diseases including cancer, rheumatoid arthritis and Alzheimer's disease. The company's patented antibody library technologies including HuCAL are used in research and diagnostics applications. Its product pipeline includes drugs in various stages of development for the treatment of different types of cancer, psoriasis, rheumatoid arthritis, COPD, asthma and other inflammatory diseases. Its cancer drug candidates include MOR208 (Phase II), MOR202 (Phase II), MOR209/ES414 (Phase I) tarextumab (Phase II and Phase I) and NOV-10 (Phase I), among others. The company’s inflammatory drug candidates comprise MOR103 (Phase II), guselkumab (Phase III and Phase II) and NOV-8 (Phase I), among others. It has research and development agreements with pharmaceutical and biotechnology companies such as Boehringer Ingelheim, GlaxoSmithKline, and Pfizer among others. Morphosys is headquartered in Planegg, Munich, Germany.

MorphoSys AG Key Recent Developments

Jul 30, 2015: MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program against a GPCR Target
Jul 27, 2015: MorphoSys Reports Results for the First Six Months of 2015
May 08, 2015: Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members
May 04, 2015: MorphoSys Reports Results for the First Three Months of 2015
Mar 30, 2015: MorphoSys Nominates Three New Candidates for Supervisory Board

This comprehensive SWOT profile of MorphoSys AG provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table Of Contents

MorphoSys AG (MOR) - Financial and Strategic SWOT Analysis Review
Table of Contents

Section 1 - About the Company

MorphoSys AG - Key Information
MorphoSys AG - Overview
MorphoSys AG - Key Employees
MorphoSys AG - Key Employee Biographies
MorphoSys AG - Key Operational Heads
MorphoSys AG - Major Products and Services
MorphoSys AG - History
MorphoSys AG - Company Statement
MorphoSys AG - Locations And Subsidiaries
MorphoSys AG - Key Manufacturing facilities
Head Office
Other Locations and Subsidiaries

Section 2 - Company Analysis

MorphoSys AG - Business Description
MorphoSys AG - Corporate Strategy
MorphoSys AG - SWOT Analysis
SWOT Analysis - Overview
MorphoSys AG - Strengths
MorphoSys AG - Weaknesses
MorphoSys AG - Opportunities
MorphoSys AG - Threats
MorphoSys AG - Key Competitors

Section 3 - Company Financial Performance Charts

MorphoSys AG - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MorphoSys AG, Key Information
MorphoSys AG, Key Ratios
MorphoSys AG, Share Data
MorphoSys AG, Major Products and Services
MorphoSys AG, History
MorphoSys AG, Key Employees
MorphoSys AG, Key Employee Biographies
MorphoSys AG, Key Operational Heads
MorphoSys AG, Other Locations
MorphoSys AG, Subsidiaries
MorphoSys AG, Key Manufacturing facilities
MorphoSys AG, Key Competitors
MorphoSys AG, SWOT Analysis
MorphoSys AG, Ratios based on current share price
MorphoSys AG, Annual Ratios
MorphoSys AG, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

MorphoSys AG, Performance Chart
MorphoSys AG, Ratio Charts

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.